RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological Tumor.

by kira@rippkedesign.com | Nov 1, 2021 | Data Papers, Journal Publications

Brzezniak C, Oronsky B, Trepel J, Summers TA Jr, Cabrales P, Lee MJ, Day R, Jha S, Caroen S, Zeman K, Ferry L, Harmer C, Oronsky N, Lybeck M, Lybeck HE, Brown JF, Reid TR, Carter CA.Case Rep Oncol. 2017 Mar 29;10(1):276-280. doi: 10.1159/000464101. eCollection 2017...

A Complete Metabolic Response of Metastatic Castration-resistant Neuroendocrine Carcinoma of the Prostate After Treatment with RRx-001 and Reintroduced Platinum Doublets.

by kira@rippkedesign.com | Nov 1, 2021 | Data Papers, Journal Publications

Brzezniak C, Oronsky B, Aggarwal R.Eur Urol. 2018 Feb;73(2):306-307. doi: 10.1016/j.eururo.2017.09.010. Epub 2017 Sep 21.PMID: 28943185 No abstract available.

Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors.

by kira@rippkedesign.com | Nov 1, 2021 | Data Papers, Journal Publications

Raghunand N, Scicinski J, Guntle GP, Jagadish B, Mash EA, Bruckheimer E, Oronsky B, Korn RL.Oncotarget. 2017 Jun 12;8(60):102511-102520. doi: 10.18632/oncotarget.18455. eCollection 2017 Nov 24.PMID: 29254266 Free PMC article.

A note on improved statistical approaches to account for pseudoprogression.

by kira@rippkedesign.com | Nov 1, 2021 | Data Papers, Journal Publications

Abrouk N, Oronsky B, Caroen S, Ning S, Knox S, Peehl D.Cancer Chemother Pharmacol. 2018 Mar;81(3):621-626. doi: 10.1007/s00280-018-3529-4. Epub 2018 Feb 5.PMID: 29404682

A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet.

by kira@rippkedesign.com | Nov 1, 2021 | Data Papers, Journal Publications

Cottrill H, Cason S, Caroen S, Oronsky B, Donaldson E.J Investig Med High Impact Case Rep. 2018 Mar 7;6:2324709618760080. doi: 10.1177/2324709618760080. eCollection 2018 Jan-Dec.PMID: 29552569 Free PMC article.